Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 60.67%
March 31, 2026 61.49%
December 31, 2025 60.06%
September 30, 2025 62.55%
June 30, 2025 61.68%
March 31, 2025 60.81%
December 31, 2024 58.88%
September 30, 2024 59.37%
June 30, 2024 60.57%
March 31, 2024 60.49%
December 31, 2023 61.23%
September 30, 2023 59.61%
June 30, 2023 60.67%
March 31, 2023 59.73%
December 31, 2022 59.51%
September 30, 2022 58.48%
June 30, 2022 59.92%
March 31, 2022 60.22%
December 31, 2021 59.52%
September 30, 2021 60.10%
June 30, 2021 60.57%
March 31, 2021 61.09%
December 31, 2020 59.29%
September 30, 2020 60.76%
June 30, 2020 60.87%
Date Value
March 31, 2020 61.68%
December 31, 2019 62.41%
September 30, 2019 62.42%
June 30, 2019 62.43%
March 31, 2019 61.76%
December 31, 2018 62.82%
September 30, 2018 61.93%
June 30, 2018 62.92%
March 31, 2018 58.91%
December 31, 2017 65.69%
September 30, 2017 65.28%
June 30, 2017 66.43%
March 31, 2017 62.96%
December 31, 2016 66.72%
September 30, 2016 63.26%
June 30, 2016 61.90%
March 31, 2016 61.97%
December 31, 2015 65.02%
September 30, 2015 61.25%
June 30, 2015 59.26%
March 31, 2015 56.61%
December 31, 2014 59.52%
September 30, 2014 62.84%
June 30, 2014 63.08%
March 31, 2014 61.51%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Alphatec Holdings, Inc. 62.90%
Glaukos Corp. 81.67%
TransMedics Group, Inc. 57.34%
Embecta Corp. 55.47%
Abbott Laboratories 52.64%

Gross Profit Margin (Quarterly) Related Metrics